Apr 21, 2025
Zimmer Biomet Completes Acquisition of Paragon 28
Apr 10, 2025
Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2025 Financial Results
Apr 01, 2025
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage® Fixation System
Mar 10, 2025
Zimmer Biomet Highlights Diverse Portfolio of Orthopedic & Musculoskeletal Innovations at AAOS 2025 Annual Meeting
Mar 07, 2025
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion(TM) Femur
Mar 06, 2025
Zimmer Biomet Names Kristen Cardillo as Senior Vice President, Chief Communications Officer
Feb 28, 2025
Zimmer Biomet to Present at the 27th Annual Barclays Healthcare Conference
Feb 27, 2025
Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer
Feb 26, 2025
Zimmer Biomet Launches You'll Be Back Campaign with Chief Movement Officer Arnold Schwarzenegger
Feb 26, 2025
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2025
Feb 25, 2025
Zimmer Biomet Announces Upcoming Changes to Company's Board of Directors
Feb 06, 2025
Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results
Jan 28, 2025
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28
Dec 20, 2024
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 18, 2024
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2024
Dec 04, 2024
Zimmer Biomet Receives FDA Clearance for Persona® SoluTion(TM) PPS® Femur
Nov 25, 2024
Zimmer Biomet Receives FDA Approval for Oxford® Cementless Partial Knee, Only Cementless Partial Knee Replacement Implant in the U.S.
Nov 21, 2024
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
Nov 07, 2024
Zimmer Biomet to Present at Jefferies London Healthcare Conference
Oct 30, 2024
Zimmer Biomet Announces Third Quarter 2024 Financial Results